SCHEMBL30641300

SCHEMBL30641300

Cc1ccnc(Nc2c(C)cccc2Br)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 7/20 0.43
▸ RAB9A P51151 6/20 0.43
▸ SMN1; SMN2 Q16637 5/20 0.43
▸ PKM P14618 3/20 0.43
▸ TP53 P04637 3/20 0.43
▸ LMNA P02545 1/20 0.43
▸ ALOX15 P16050 1/20 0.43
▸ ALDH1A1 P00352 3/20 0.41
▸ MAPT P10636 2/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.40
▸ SYK P43405 1/20 0.38
▸ KMT2A Q03164 2/20 0.37
▸ PIK3CA P42336 1/20 0.37
▸ PIK3CG P48736 1/20 0.37
▸ POLB P06746 1/20 0.37
▸ KDR P35968 1/20 0.37
▸ MEN1 O00255 1/20 0.36
▸ CYP2C9 P11712 1/20 0.35
▸ GRM8 O00222 1/20 0.35
▸ GRM4 Q14833 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26674581 1.00 NPC1 (0.43) NPC1RAB9ASMN1; SMN2PKMTP53
SCHEMBL26674738 0.85 ALDH1A1 (0.40) NPC1RAB9ASMN1; SMN2ALDH1A1MAPT
SCHEMBL30641206 0.85 NPC1 (0.42) NPC1RAB9ASMN1; SMN2PKMTP53
SCHEMBL26674594 0.85 NPC1 (0.42) NPC1RAB9ASMN1; SMN2PKMTP53
SCHEMBL2229315 0.73 NPC1 (0.44) NPC1RAB9ASMN1; SMN2PKMTP53
SCHEMBL4624975 0.69 NPC1 (0.65) NPC1RAB9ASMN1; SMN2PKMTP53
SCHEMBL2504479 0.69 SYK (0.46) NPC1RAB9ASMN1; SMN2PKMTP53
SCHEMBL14088797 0.68 PIK3CA (0.62) SYKKMT2APIK3CAPIK3CGKDR
SCHEMBL15478540 0.67 CXCR2 (0.51) RAB9ALMNAALOX15ALDH1A1MAPT
SCHEMBL15185772 0.67 PLK1 (0.52) NPC1RAB9ASMN1; SMN2PKMTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119894872-A Heteroarenes, pharmaceutical compositions containing heteroarenes, and methods of use thereof 修复治疗公司 2025-04-25 — — CN disclosed
EP-4526293-A1 HETEROARENES, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME, AND METHODS OF USING THE SAME Repare Therapeutics Inc. (CA) 2025-03-26 — — EP disclosed
WO-2023220831-A1 HETEROARENES, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME, AND METHODS OF USING THE SAME REPARE THERAPEUTICS INC. (CA) 2023-11-23 — — WO disclosed
Send feedback